PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections

Disease due to pulmonary Aspergillus infection remains a significant unmet need, particularly in immunocompromised patients, patients in critical care and those with underlying chronic lung diseases. To date, treatment using inhaled antifungal agents has been limited to repurposing available systemi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Fungi (Basel)
Autores principales: Murray, Alison, Cass, Lindsey, Ito, Kazuhiro, Pagani, Nicole, Armstrong-James, Darius, Dalal, Paras, Reed, Anna, Strong, Pete
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7765807/
https://ncbi.nlm.nih.gov/pubmed/33348852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jof6040373
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares